CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells

被引：0

作者：

Kawabata, Ayako ^{[1
,2
]}

Hayashi, Tomoatsu ^{[1
]}

Akasu-Nagayoshi, Yoko ^{[1
,2
]}

Yamada, Ai ^{[1
]}

Shimizu, Naomi ^{[1
]}

Yokota, Naoko ^{[3
]}

Nakato, Ryuichiro ^{[3
]}

Shirahige, Katsuhiko ^{[4
]}

Okamoto, Aikou ^{[2
]}

Akiyama, Tetsu ^{[1
]}

机构：

[1] Univ Tokyo, Inst Quantitat Biosci, Lab Mol & Genet Informat, Tokyo 1130032, Japan

[2] Jikei Univ, Dept Obstet & Gynecol, Sch Med, Tokyo 1058461, Japan

[3] Univ Tokyo, Inst Quantitat Biosci, Lab Computat Genet, Tokyo 1130032, Japan

[4] Univ Tokyo, Inst Quantitat Biosci, Lab Genome Struct & Funct, Tokyo 1130032, Japan

来源：

CURRENT ISSUES IN MOLECULAR BIOLOGY | 2022年 / 44卷 / 04期

基金：

日本学术振兴会;

关键词：

ovarian cancer; ovarian clear cell carcinoma; CRISPR; Cas9; system; proliferation; tumorigenesis; POOR-PROGNOSIS; CANCER; MUTATIONS; ARID1A;

D O I：

10.3390/cimb44040108

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Epithelial ovarian cancer is classified into four major histological subtypes: serous, clear cell, endometrioid and mucinous. Ovarian clear cell carcinoma (OCCC) responds poorly to conventional chemotherapies and shows poor prognosis. Thus, there is a need to develop new drugs for the treatment of OCCC. In this study, we performed CRISPR/Cas9 screens against OCCC cell lines and identified candidate genes important for their proliferation. We found that quite different genes are required for the growth of ARID1A and PIK3CA mutant and wild-type OCCC cell lines, respectively. Furthermore, we found that the epigenetic regulator KDM2A and the translation regulator PAIP1 may play important roles in the growth of ARID1A and PIK3CA mutant, but not wild-type, OCCC cells. The results of our CRISPR/Cas9 screening may be useful in elucidating the molecular mechanism of OCCC tumorigenesis and in developing OCCC-targeted drugs.

引用

页码：1587 / 1596

页数：10

共 41 条

[11] Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
Gilks, C. Blake
Ionescu, Diana N.
Kalloger, Steve E.
Koebel, Martin
Irving, Julie
Clarke, Blaise
Santos, Jennifer
Le, Nhu
Moravan, Veronika
Swenerton, Kenneth
[J]. HUMAN PATHOLOGY, 2008, 39 (08) : 1239 - 1251
[12] Role of Paip1 on angiogenesis and invasion in pancreatic cancer
Guan, Hongjian
Li, Nan
Wang, Xinyue
Shan, Xinyu
Li, Zhuhu
Lin, Zhenhua
[J]. EXPERIMENTAL CELL RESEARCH, 2019, 376 (02) : 198 - 209
[13] Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens
Hart, Traver
Tong, Amy Hin Yan
Chan, Katie
Van Leeuwen, Jolanda
Seetharaman, Ashwin
Aregger, Michael
Chandrashekhar, Megha
Hustedt, Nicole
Seth, Sahil
Noonan, Avery
Habsid, Andrea
Sizova, Olga
Nedyalkova, Lyudmila
Climie, Ryan
Tworzyanski, Leanne
Lawson, Keith
Sartori, Maria Augusta
Alibeh, Sabriyeh
Tieu, David
Masud, Sanna
Mero, Patricia
Weiss, Alexander
Brown, Kevin R.
Usaj, Matej
Billmann, Maximilian
Rahman, Mahfuzur
Constanzo, Michael
Myers, Chad L.
Andrews, Brenda J.
Boone, Charles
Durocher, Daniel
Moffat, Jason
[J]. G3-GENES GENOMES GENETICS, 2017, 7 (08): : 2719 - 2727
[14] Clear cell carcinoma of the ovary: a clinical and molecular perspective
Iida, Yasushi
Okamoto, Aikou
Hollis, Robert L.
Gourley, Charlie
Herrington, C. Simon
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (04) : 605 - 616
[15] Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
Itamochi, Hiroaki
Kigawa, Junzo
Terakawa, Naoki
[J]. CANCER SCIENCE, 2008, 99 (04) : 653 - 658
[16] Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, Sian
Wang, Tian-Li
Shih, Ie-Ming
Mao, Tsui-Lien
Nakayama, Kentaro
Roden, Richard
Glas, Ruth
Slamon, Dennis
Diaz, Luis A., Jr.
Vogelstein, Bert
Kinzler, Kenneth W.
Velculescu, Victor E.
Papadopoulos, Nickolas
[J]. SCIENCE, 2010, 330 (6001) : 228 - 231
[17] The histone demethylase Fbxl11/Kdm2a plays an essential role in embryonic development by repressing cell-cycle regulators
Kawakami, Eri
Tokunaga, Akinori
Ozawa, Manabu
Sakamoto, Reiko
Yoshida, Nobuaki
[J]. MECHANISMS OF DEVELOPMENT, 2015, 135 : 31 - 42
[18] Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C
Kolendowski, Bart
Valdes, Yudith Ramos
Hirte, Hal
Itamochi, Hiroaki
Lee, Wonjae
Carey, Mark
Shepherd, Trevor G.
DiMattia, Gabriel E.
[J]. CELLS, 2020, 9 (11) : 1 - 24
[19] Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study
Ku, Fei-Chun
Wu, Ren-Chin
Yang, Lan-Yan
Tang, Yun-Hsin
Chang, Wei-Yang
Yang, Jung-Erh
Wang, Chun-Chieh
Jung, Shih-Ming
Lin, Cheng-Tao
Chang, Ting-Chang
Chao, Angel
Lai, Chyong-Huey
[J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2018, 117 (02) : 117 - 125
[20] Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuo, Kuan-Ting
Mao, Tsui-Lien
Jones, Sian
Veras, Emanuela
Ayhan, Ayse
Wang, Tian-Li
Glas, Ruth
Slamon, Dennis
Velculescu, Victor E.
Kuman, Robert J.
Shih, Ie-Ming
[J]. AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (05) : 1597 - 1601

← 1 2 3 4 5 →